Medication Guide App

Zanamivir

In the US, Zanamivir (zanamivir systemic) is a member of the following drug classes: inhaled anti-infectives, neuraminidase inhibitors and is used to treat Influenza, Influenza Prophylaxis and Swine Flu.

US matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

J05AH01

CAS registry number (Chemical Abstracts Service)

0139110-80-8

Chemical Formula

C12-H20-N4-O7

Molecular Weight

332

Therapeutic Categories

Antiviral agent

Neuraminidase inhibitor

Treatment of influenza

Chemical Name

D-glycero-D-galacto-Non-2-enonic acid, 5-(acetylamino)-4-[(aminoiminoethyl)amino]-2,6-anhydro-3,4,5-trideoxy-

Foreign Names

  • Zanamivirum (Latin)
  • Zanamivir (German)
  • Zanamivir (French)
  • Zanamivir (Spanish)

Generic Names

  • Zanamivir (OS: BAN, USAN, DCF)
  • GG 167 (IS: GlaxoWellcome)
  • GR 121167 X (IS: GlaxoWellcome)

Brand Names

  • Relenza
    GlaxoSmithKline, Germany; Glaxo Wellcome, Portugal; Glaxo Wellcome, Serbia; GlaxoSmithKline, Austria; GlaxoSmithKline, Australia; GlaxoSmithKline, Belgium; GlaxoSmithKline, Bulgaria; GlaxoSmithKline, Canada; GlaxoSmithKline, Switzerland; GlaxoSmithKline, China; GlaxoSmithKline, Czech Republic; GlaxoSmithKline, Denmark; GlaxoSmithKline, Estonia; GlaxoSmithKline, Spain; GlaxoSmithKline, Finland; GlaxoSmithKline, France; GlaxoSmithKline, United Kingdom; GlaxoSmithKline, Georgia; GlaxoSmithKline, Greece; GlaxoSmithKline, Hong Kong; GlaxoSmithKline, Croatia (Hrvatska); GlaxoSmithKline, Israel; GlaxoSmithKline, Iceland; GlaxoSmithKline, Italy; GlaxoSmithKline, Japan; GlaxoSmithKline, Lithuania; GlaxoSmithKline, Luxembourg; GlaxoSmithKline, Latvia; GlaxoSmithKline, Myanmar; GlaxoSmithKline, Malta; GlaxoSmithKline, Mexico; GlaxoSmithKline, Malaysia; GlaxoSmithKline, Netherlands; GlaxoSmithKline, Norway; GlaxoSmithKline, New Zealand; GlaxoSmithKline, Oman; GlaxoSmithKline, Poland; GlaxoSmithKline, Romania; GlaxoSmithKline, Serbia; GlaxoSmithKline, Russian Federation; GlaxoSmithKline, Sweden; GlaxoSmithKline, Singapore; GlaxoSmithKline, Slovenia; GlaxoSmithKline, Slovakia; GlaxoSmithKline, Tunisia; GlaxoSmithKline, Turkey; GlaxoSmithKline, Taiwan; GlaxoSmithKline, United States; GlaxoSmithKline, South Africa
  • Zanamivir - Simcere Pharm
    Simcere, China

International Drug Name Search

Glossary

TermDefinition
BANBritish Approved Name
DCFDénomination Commune Française
ISInofficial Synonym
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide
(web1)